Skip to Main Content

Molecular and Functional Characterization of a Patient-Derived Organoid Platform for Ovarian Cancer

Establishing a national registry of clear cell and mucinous ovarian cancers

Identifying biomarkers of immunotherapy response in ovarian clear cell carcinoma

Testing a novel treatment target in clear cell ovarian cancer

Developing new treatments for clear cell ovarian cancer